MarketCap
Facebook
X
TelegramAnnual report 2025
added 04-18-2026
Alcon DIO Ratio 2011-2026 | ALC
Annual DIO Ratio Alcon
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | - | - | - | 126 | 119 | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 126 | 119 | 123 |
DIO Ratio of other stocks in the Medical instruments industry
| Issuer | DIO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
The Cooper Companies
COO
|
213 | $ 60.38 | 1.53 % | $ 12 B |  USA |
 |
Atrion Corporation
ATRI
|
253 K | - | - | $ 810 M | USA |
 |
iRhythm Technologies
IRTC
|
29.6 | - | - | $ 3.65 B | USA |
 |
Intuitive Surgical
ISRG
|
177 | - | - | $ 153 B | USA |
 |
Luminex Corporation
LMNX
|
265 | - | - | $ 1.75 B | USA |
 |
ICU Medical
ICUI
|
155 | $ 122.99 | 0.78 % | $ 3.03 B | USA |
 |
Repro Med Systems
KRMD
|
76.2 | $ 3.98 | 3.38 % | $ 184 M | USA |
 |
Akers Biosciences, Inc.
AKER
|
66.1 | - | -9.52 % | $ 20.6 M | USA |
 |
LeMaitre Vascular
LMAT
|
338 | - | - | $ 2.25 B | USA |
 |
Masimo Corporation
MASI
|
168 | - | - | $ 9.51 B | USA |
 |
Antares Pharma, Inc.
ATRS
|
105 | - | - | $ 955 M | USA |
 |
Cantel Medical Corp.
CMD
|
106 | - | -1.18 % | $ 3.4 B | USA |
 |
CRH Medical Corporation
CRHM
|
0.917 | - | - | $ 282 M | USA |
 |
Hill-Rom Holdings, Inc.
HRC
|
91.4 | - | -0.05 % | $ 10.3 B | USA |
 |
Ekso Bionics Holdings
EKSO
|
288 | - | - | $ 28.6 M | USA |
 |
Envista Holdings Corporation
NVST
|
78.3 | $ 23.86 | -0.25 % | $ 4.01 B | USA |
 |
Varian Medical Systems, Inc.
VAR
|
105 | - | -0.02 % | $ 16.3 B | USA |
 |
electroCore
ECOR
|
142 | $ 6.43 | 1.74 % | $ 54.5 K | USA |
 |
STERIS plc
STE
|
75 | $ 215.98 | 2.31 % | $ 21.3 B | USA |
 |
Haemonetics Corporation
HAE
|
204 | $ 57.12 | 0.19 % | $ 2.87 B | USA |
 |
Teleflex Incorporated
TFX
|
149 | $ 130.28 | 0.18 % | $ 5.81 B | USA |
 |
STAAR Surgical Company
STAA
|
164 | $ 32.01 | 8.88 % | $ 1.59 B | USA |
 |
Isoray
ISR
|
159 | - | 0.03 % | $ 108 M | USA |
 |
Glaukos Corporation
GKOS
|
193 | $ 142.15 | 3.54 % | $ 6.88 B | USA |
 |
InfuSystem Holdings
INFU
|
34.5 | $ 8.61 | 4.87 % | $ 178 M | USA |
 |
Milestone Scientific
MLSS
|
533 | $ 0.34 | -5.04 % | $ 27.9 M | USA |
 |
Merit Medical Systems
MMSI
|
150 | $ 62.56 | -0.1 % | $ 3.7 B | USA |
 |
Utah Medical Products
UTMD
|
185 | $ 63.7 | -0.55 % | $ 206 M | USA |
 |
West Pharmaceutical Services
WST
|
76 | $ 300.19 | -0.73 % | $ 21.7 B | USA |
 |
Pulse Biosciences
PLSE
|
46 | $ 27.1 | 13.11 % | $ 1.83 B | USA |
 |
DENTSPLY SIRONA
XRAY
|
120 | $ 10.41 | -0.29 % | $ 2.08 B | USA |
 |
Retractable Technologies
RVP
|
174 | $ 0.69 | -1.42 % | $ 20.7 M | USA |
 |
Pro-Dex
PDEX
|
145 | $ 58.65 | 2.11 % | $ 193 M | USA |
 |
Predictive Oncology
POAI
|
1.12 K | - | - | $ 31.1 M | USA |
 |
BioLife Solutions
BLFS
|
317 | $ 21.06 | -0.52 % | $ 1.01 B | USA |
 |
Stereotaxis
STXS
|
213 | - | - | $ 176 M | USA |
 |
Baxter International
BAX
|
99.3 | $ 17.78 | 2.72 % | $ 9.12 B | USA |
 |
ResMed
RMD
|
141 | $ 202.46 | 0.34 % | $ 29.6 B | USA |
 |
AtriCure
ATRC
|
210 | $ 28.15 | 5.87 % | $ 1.34 B | USA |
 |
Harvard Bioscience
HBIO
|
219 | $ 5.52 | -0.81 % | $ 245 M | USA |
 |
NeuroMetrix
NURO
|
392 | - | 5.05 % | $ 9.02 M | USA |
 |
AngioDynamics
ANGO
|
166 | $ 11.03 | 1.75 % | $ 451 M | USA |
 |
Becton, Dickinson and Company
BDX
|
119 | - | - | $ 41.6 B | USA |
 |
Nephros
NEPH
|
149 | $ 3.34 | -5.92 % | $ 35.4 M | USA |
 |
OraSure Technologies
OSUR
|
178 | $ 2.95 | -2.96 % | $ 217 M | USA |
 |
Repligen Corporation
RGEN
|
162 | $ 103.38 | -3.41 % | $ 5.81 M | USA |